Piramal Healthcare is to announce its fourth quarter results. According to CNBC-TV18's estimates, the company's Q4FY11 revenues are seen down 48% at Rs 492 crore versus Rs 942 crore, year-on-year, YoY.
Its EBITDA is seen down at Rs 39 crore versus Rs 221 crore, YoY. Its OPM is seen down 8% versus 23.5%, YoY. The company's PAT is seen down 13% at Rs 68 crore versus Rs 154 crore, YoY. Year-on-year numbers not comparable due to hiving off of domestic formulation business With Full Effect Q3FY11 Q4FY11 QoQDiscover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
